Liquid–liquid phase separation‐related gene in gliomas: FABP5 is a potential prognostic marker
The Journal of Gene Medicine · 2023
DOI: 10.1002/jgm.3517 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2023. Verfasst von Qikai Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Glioma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
The glioma is the most malignant human brain tumor. Early glioma detection and treatment are still difficult. New biomarkers are desperately required to aid in the evaluation of diagnosis and prognosis.
Methods
The single cell sequencing dataset scRNA‐6148 for glioblastoma was obtained from the Chinese Glioma Genome Atlas database. Data were gathered for the transcriptome sequencing project. Genes involved in liquid–liquid phase separation (LLPS) were taken out of the DrLLPS database. To find the modules connected to LLPS, the weighted co‐expression network was analyzed. Differential expression analysis was used to identify the differentially expressed genes (DEGs) in gliomas. Pseudo‐time series analysis, gene set enrichment analysis (GSEA) and immune cell infiltration analysis were used to investigate the role of important genes in the immunological microenvironment. We examined the function of key glioma genes using polymerase chain reaction (PCR) testing, CCK‐8 assays, clone generation assays, transwell assays and wound healing assays.
Results
FABP5 was identified as a key gene in glioblastoma by multiomics research. Pseudo‐time series analysis showed that FABP5 was highly linked with the differentiation of many different types of cells. GSEA revealed that FABP5 was strongly linked to several hallmark pathways in glioblastoma. We looked at immune cell infiltration and discovered a significant link between FABP5, macrophages and T cell follicular helpers. The PCR experiment results demonstrated that FABP5 expression was elevated in glioma samples. Cell experiments showed that FABP5 knockdown dramatically decreased the viability, proliferation, invasion and migration of the LN229 and U87 glioma cell lines.
Conclusions
Our study provides a new biomarker, FABP5, for glioma diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
- Department of Neurosurgery, Pukou Branch of Jiangsu People's Hospital, Nanjing Pukou District Central Hospital, Nanjing, China.
- Department of Neurosurgery, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
- Department of Orthopaedics, Jinling Hospital, Nanjing Medical University, Nanjing, China.
Zitieren
APA
Tang, Q., Mao, X., Chen, Z., Ma, C., Tu, Y., Zhu, Q., Lu, J., Wang, Z., Zhang, Q., & Wu, W. (2023). Liquid–liquid phase separation‐related gene in gliomas: FABP5 is a potential prognostic marker. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3517
Vancouver
Tang Q, Mao X, Chen Z, Ma C, Tu Y, Zhu Q, et al. Liquid–liquid phase separation‐related gene in gliomas: FABP5 is a potential prognostic marker. The Journal of Gene Medicine. 2023. doi:10.1002/jgm.3517
BibTeX
@article{Tang2023,
author = {Tang, Qikai and Mao, Xiaoman and Chen, Zhengxin and Ma, Chenfeng and Tu, Yiming and Zhu, Qianmiao and Lu, Jiacheng and Wang, Zhen and Zhang, Qixiang and Wu, Wei},
title = {Liquid–liquid phase separation‐related gene in gliomas: FABP5 is a potential prognostic marker},
journal = {The Journal of Gene Medicine},
year = {2023},
doi = {10.1002/jgm.3517}
}
EUVIMED